Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD

Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD

Nirupama Putcha,1 Ayca Ozol-Godfrey,2 Shahin Sanjar,2 Sanjay Sharma2 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2Sunovion Pharmaceuticals Inc., Marlborough, MA, USACorrespondence: Nirupama PutchaDivision of Pulmonary and Critic...

Full description

Bibliographic Details
Main Authors: Putcha N, Ozol-Godfrey A, Sanjar S, Sharma S
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:International Journal of COPD
Subjects:
comorbidities
copd
cardiovascular disease
lama
nebulized glycopyrrolate
Online Access:https://www.dovepress.com/impact-of-comorbidity-prevalence-and-cardiovascular-disease-status-on--peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/impact-of-comorbidity-prevalence-and-cardiovascular-disease-status-on--peer-reviewed-fulltext-article-COPD

Similar Items